Return of spermatogenesis after stopping cyclophosphamide therapy
- PMID: 49747
- DOI: 10.1016/s0140-6736(75)90059-8
Return of spermatogenesis after stopping cyclophosphamide therapy
Abstract
A follow-up of twenty-six male patients with azoospermia after stopping cyclophosphamide treatment showed a return of spermatogenesis in twelve patients within 15-49 months (mean 31 months). In one patient spermatogenesis returned despite 34 months of treatment with 100 mg. of cyclophosphamide daily. The period of follow-up after stopping cyclophosphamide therapy varied from 5 months to 4 years. After 6 months on cyclophosphamide all patients remained azoospermic while taking the drug. Return of spermatogenesis was not significantly associated with age, duration of cyclophosphamide therapy, total dose, or time of follow-up after stopping treatment; however, the number of patients in the study was small.
Similar articles
-
Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.Hum Reprod. 2016 Feb;31(2):263-72. doi: 10.1093/humrep/dev310. Epub 2015 Dec 23. Hum Reprod. 2016. PMID: 26705149
-
Cyclophosphamide therapy and sterility.Lancet. 1972 Dec 16;2(7790):1290-1. doi: 10.1016/s0140-6736(72)92657-8. Lancet. 1972. PMID: 4117814 No abstract available.
-
Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.Fertil Steril. 2014 Sep;102(3):667-674.e3. doi: 10.1016/j.fertnstert.2014.06.008. Epub 2014 Jul 17. Fertil Steril. 2014. PMID: 25044088
-
Hormonal strategies for fertility preservation in patients receiving cyclophosphamide to treat glomerulonephritis: a nonrandomized trial and review of the literature.Am J Kidney Dis. 2008 Nov;52(5):887-96. doi: 10.1053/j.ajkd.2008.06.017. Am J Kidney Dis. 2008. PMID: 18971013 Review.
-
Environmental pollutants: genetic damage and epigenetic changes in male germ cells.Environ Sci Pollut Res Int. 2016 Dec;23(23):23339-23348. doi: 10.1007/s11356-016-7728-4. Epub 2016 Sep 26. Environ Sci Pollut Res Int. 2016. PMID: 27672044 Review.
Cited by
-
D-Tryptophan-6 analog of luteinizing hormone-releasing hormone as a protective agent against testicular damage caused by cyclophosphamide in baboons.Proc Natl Acad Sci U S A. 1985 May;82(9):2975-9. doi: 10.1073/pnas.82.9.2975. Proc Natl Acad Sci U S A. 1985. PMID: 3157995 Free PMC article.
-
Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group.J Clin Oncol. 2012 Sep 20;30(27):3408-16. doi: 10.1200/JCO.2011.38.6938. Epub 2012 May 29. J Clin Oncol. 2012. PMID: 22649147 Free PMC article.
-
Recovery of Spermatogenesis Following Cancer Treatment with Cytotoxic Chemotherapy and Radiotherapy.World J Mens Health. 2019 May;37(2):166-174. doi: 10.5534/wjmh.180043. Epub 2018 Nov 27. World J Mens Health. 2019. PMID: 30588779 Free PMC article. Review.
-
Oncofertility in adult and pediatric populations: options and barriers.Transl Androl Urol. 2020 Mar;9(Suppl 2):S227-S238. doi: 10.21037/tau.2019.09.27. Transl Androl Urol. 2020. PMID: 32257863 Free PMC article. Review.
-
Treatment of childhood cancer: effects on the gonads.Br Med J. 1978 Sep 16;2(6140):785-6. doi: 10.1136/bmj.2.6140.785. Br Med J. 1978. PMID: 698734 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources